Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
Guardant to Fundamentally Change Mortality Curves in Cancer, CEO Says
Posted
October 5, 2018
Views
2,200
Likes
24
Engagement
1.09%
October 5, 2018
2,200
24
1.09%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
7:03Now PlayingOct.05 -- Guardant Health Inc., a cancer-detection firm backed by SoftBank Group Corp., raised $237.5 million in its U.S. initial public offering. Bloomberg's Alex Barinka talks with Helmy Eltoukhy, chief executive officer and co-founder of Guardant, about the company's business model and growth opportunities.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
